20mg
Lyophilized Vial
For Research Purposes Only
Trizepatide
20mg
Dual GIP/GLP-1 receptor agonist
In Stock
$70.00AUD / single
Buy 3 — Save 10%$63.00 each3 for $189.00 — save $21.00
Gallery
Product Images
Description
About Trizepatide
A dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist studied in preclinical metabolic research for weight regulation, glycemic control, and appetite signaling.
Composition
Ingredients
- ◆Trizepatide (20mg lyophilized)
- ◆Mannitol carrier
Research Applications
Studied Benefits
01
Studied for dual incretin receptor agonism
02
Investigated in weight and adiposity research models
03
Explored for glucose homeostasis and satiety pathways
Important
Not for human consumption. Sold strictly for in-vitro research and laboratory use. Buyer assumes all responsibility for use.